IP Library Granted Patent US 11,559,601
Granted Patent B2
US 11,559,601 · App. 17/179,013 · Granted Jan 24, 2023

Hemostatic devices

Inventors: Dina Dubey (Fairfield, NJ); Denny Lo (Bethlehem, CT)
Assignee: Teleflex Life Sciences Limited
A61L15/28A61L15/18A61L15/44A61L15/46A61L2300/102A61L2300/104A61L2300/402A61L2300/404A61L2300/406A61L2300/41A61L2300/418A61L2300/432A61L2400/04A61L2420/02A61L2420/04A61L2420/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,559,601
App. No.
17/179,013
Granted
Jan 24, 2023
Kind
B2
Abstract

Hemostatic devices for promoting blood clotting can include a substrate (e.g., gauze, textile, sponge, sponge matrix, one or more fibers, etc.), a hemostatic material disposed thereon such as kaolin clay, and a binder material such as crosslinked calcium alginate with a high guluronate monomer molar percentage disposed on the substrate to substantially retain the hemostatic material material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood to accelerate clotting. Moreover, when exposed to blood, the binder has low solubility and retains a majority of the clay material on the gauze. A bandage that can be applied to a bleeding wound to promote blood clotting includes a flexible substrate and a gauze substrate mounted thereon.

Claims (17)

1. A hemostatic device comprising:

a gauze substrate;

a hemostatic aluminosilicate; and

a water-insoluble, crosslinkable, biocompatible, polymeric binder configured to immobilize the hemostatic aluminosilicate on the substrate such that the hemostatic aluminosilicate does not visibly separate from the substrate in the presence of water;

wherein the hemostatic device is not saturated before use;

wherein the binder resists dissolving in blood;

wherein the device is configured such that when treating bleeding, application of the device is capable of causing blood to be absorbed into the gauze substrate and causing at least a portion of the hemostatic aluminosilicate to come into direct contact with blood to assist in accelerating clotting, but the device resists releasing the hemostatic material into a bleeding wound.

2. The hemostatic device of claim 1 , wherein the water-insoluble, crosslinkable, biocompatible, polymeric binder is a crosslinked binder.

3. The hemostatic device of claim 2 , wherein the water-insoluble, crosslinkable, biocompatible, polymeric binder includes covalent crosslinks.

4. The hemostatic device of claim 2 , wherein the water-insoluble, crosslinkable, biocompatible, polymeric binder includes ionic crosslinks.

5. The hemostatic device of claim 2 , wherein the water-insoluble, crosslinkable, biocompatible, polymeric binder includes ionic and covalent crosslinks.

6. The hemostatic device of claim 1 , wherein there is virtually no cross-linking between the hemostatic aluminosilicate and the binder.

7. The hemostatic device of claim 1 , wherein the hemostatic device is flexible to allow the hemostatic device to form to a shape of the bleeding wound and to retain a shape of the bleeding wound.

8. The hemostatic device of claim 1 , wherein the binder is applied to the gauze substrate by a spraying process.

9. The hemostatic device of claim 1 , wherein the binder is applied to the gauze substrate by immersing the gauze substrate in a liquid comprising the binder.

10. The hemostatic device of claim 1 , wherein the binder is applied to the gauze substrate using a roller.

11. The hemostatic device of claim 1 , the binder is applied to the gauze substrate using a slot die.

Assignments (8)
SECURITY INTEREST Recorded Mar 1, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066723/0376 →
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066616/0701 →
CHANGE OF NAME Recorded Feb 16, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066621/0882 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066621/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
Continuity (7)
Continuation 15429935 · Feb 10, 2017
Continuation 15071520 · Mar 16, 2016
Continuation 14720142 · May 22, 2015
Continuation 13922115 · Jun 19, 2013
Provisional Application 61754129 · Jan 18, 2013
Provisional Application 61663412 · Jun 22, 2012
Related Publication 20210178011A1 · Jun 17, 2021
Cited By (1)
US 12,685,799